ACADIA Pharmaceuticals
ACAD
$15.28
Share price
0.46%
Change (1 day)
-28.70%
Change (1 year)
Categories
Earnings for ACADIA Pharmaceuticals (ACAD)
Earnings in 2023 (TTM): -$51.04 M
According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -$51.04 M. In 2022 the company made an earning of -$0.22 B a decrease over its 2021 earnings that were of -$0.17 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for ACADIA Pharmaceuticals from 2003 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$51.04 M | -76.09% |
| 2022 | -$0.22 B | 27.41% |
| 2021 | -$0.17 B | -40.38% |
| 2020 | -$0.29 B | 19.88% |
| 2019 | -$0.24 B | -3.92% |
| 2018 | -$0.25 B | -15.04% |
| 2017 | -$0.29 B | 6.33% |
| 2016 | -$0.28 B | 64.55% |
| 2015 | -$0.17 B | 77.47% |
| 2014 | -$92.48 M | 143.69% |
| 2013 | -$37.95 M | 81.93% |
| 2012 | -$20.86 M | -8.73% |
| 2011 | -$22.86 M | -251.39% |
| 2010 | $15.09 M | -133.2% |
| 2009 | -$45.47 M | -30.82% |
| 2008 | -$65.73 M | 6.43% |
| 2007 | -$61.76 M | 25.89% |
| 2006 | -$49.06 M | 36.99% |
| 2005 | -$35.81 M | 37.22% |
| 2004 | -$26.1 M | 19.96% |
| 2003 | -$21.76 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $21.36 B | -41,958.69% | 🇺🇸 USA |
 Pfizer PFE | $3.26 B | -6,501.36% | 🇺🇸 USA |
 Eli Lilly LLY | $7.56 B | -14,915.03% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | -$5.85 B | 11,354.66% | 🇺🇸 USA |
 Vanda Pharmaceuticals VNDA | -$13.96 M | -72.66% | 🇺🇸 USA |
 Adamas Pharmaceuticals
ADMS | -$38.63 M | -24.31% | 🇺🇸 USA |